SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-061576
Filing Date
2018-12-07
Accepted
2018-12-07 17:39:56
Documents
1
Period of Report
2018-12-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3899
  Complete submission text file 0001209191-18-061576.txt   5387
Mailing Address C/O ANTHERA PHARMACEUTICALS, INC. 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address
Thompson Peter A. (Reporting) CIK: 0001357522 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38756 | Film No.: 181224416

Mailing Address 11099 NORTH TORREY PINES ROAD, SUITE 290 LA JOLLA CA 92037
Business Address 11099 NORTH TORREY PINES ROAD, SUITE 290 LA JOLLA CA 92037 858-750-4715
Synthorx, Inc. (Issuer) CIK: 0001609727 (see all company filings)

IRS No.: 464709185 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences